 |
|
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
Eun Joo Song, Kye Hwa Jeong, Young Ae Yang, Jeong-Hoon Lim, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park
Kidney Res Clin Pract. 2018;37(3):248-256. Published online 2018 Sep 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.3.248
|
|
Citations to this article as recorded by
 Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy
Xiaoqing Chen, Yong Zhang, Liqun Yan, Yangbin Xie, Shujing Li, Yongze Zhuang, Liping Wang
Clinical and Experimental Nephrology.2024; 28(5): 409. CrossRef Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy
Roza Motavalli, Maryam Hosseini, Mohammad Sadegh Soltani-Zangbar, Abbas Karimi, Mohammadreza Sadeghi, Sanam Dolati, Mehdi Yousefi, Jalal Etemadi
Molecular and Cellular Probes.2023; 69: 101914. CrossRef The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
Olga Lesya Kukuy, Ron Cohen, Boris Gilburd, Eleanor Zeruya, Talia Weinstein, Timna Agur, Dganit Dinour, Pazit Beckerman, Alexander Volkov, Johnatan Nissan, Tima Davidson, Howard Amital, Yehuda Shoenfeld, Ora Shovman
International Journal of Molecular Sciences.2023; 24(10): 9051. CrossRef Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis
Jialing Zhang, Zhengjia Fan, Peixin Wang, Ai-Hua Zhang
Kidney and Blood Pressure Research.2023; 48(1): 102. CrossRef The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
Iwona Smarz-Widelska, Dariusz Chojęta, Małgorzata M. Kozioł
International Journal of Environmental Research and Public Health.2022; 19(9): 5301. CrossRef Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy
Hyung Ah Jo, Jin Seong Hyeon, Seung Hee Yang, Youngae Jung, Hunjoo Ha, Chang Wook Jeong, Cheol Kwak, Yaerim Kim, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Geum-Sook Hwang, Dong Ki Kim
Kidney International.2021; 99(2): 443. CrossRef Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
Peihong Yin, Junxian Wang, Wenyi Liang, Linda Zhan, Yuanhao Liu, Jian Lin, Xiaohong Chen, Yingqin He, Hongyun Jian, Zhibin Xie, Xiaofan Tan, Qing Ye, Fengxian Huang
Renal Failure.2020; 42(1): 675. CrossRef Comparative analysis of immunoassay methods for the determination of circulating antibodies to the phospholipase A2 receptor
O. V. Galkina, E. O. Bogdanova, I. M. Zubina, E. N. Levykina, S. V. Lapin, O. Yu. Tkachenko, A. V. Mazing, V. A. Dobronravov, A. V. Smirnov
Nephrology (Saint-Petersburg).2020; 24(6): 71. CrossRef The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis
Si-jie Rao, Qing Shen, Hong-mei Wang, Shi Tang, Xiang-yan Wang
International Urology and Nephrology.2020; 52(11): 2123. CrossRef Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis
Weiying Li, Yuliang Zhao
International Urology and Nephrology.2019; 51(9): 1581. CrossRef Molecular classification of membranous nephropathy
Agnieszka Pozdzik, Fahd Touzani, Isabelle Brochériou, Francis Corazza
Current Opinion in Nephrology and Hypertension.2019; 28(4): 336. CrossRef Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis
Yufeng Liang, Jianxin Wan, Yongping Chen, Yangbin Pan
BMC Nephrology.2019;[Epub] CrossRef Anti-phospholipase A2 receptor antibodies in membranous nephropathy
Sangho Lee
Kidney Research and Clinical Practice.2018; 37(3): 181. CrossRef
|